Crinetics Short Long Term Debt Total from 2010 to 2024

CRNX Stock  USD 46.86  0.61  1.29%   
Crinetics Pharmaceuticals Short and Long Term Debt Total yearly trend continues to be fairly stable with very little volatility. Short and Long Term Debt Total is likely to outpace its year average in 2024. During the period from 2010 to 2024, Crinetics Pharmaceuticals Short and Long Term Debt Total regression line of annual values had r-squared of  0.42 and arithmetic mean of  8,745,693. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2019-03-31
Previous Quarter
51.7 M
Current Value
52.5 M
Quarterly Volatility
17.3 M
 
Covid
Check Crinetics Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Crinetics main balance sheet or income statement drivers, such as Net Interest Income of 14.1 M, Interest Income of 14.1 M or Depreciation And Amortization of 760.2 K, as well as many exotic indicators such as Price To Sales Ratio of 918, Dividend Yield of 0.0 or PTB Ratio of 4.02. Crinetics financial statements analysis is a perfect complement when working with Crinetics Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Crinetics Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Crinetics Pharmaceuticals Technical models . Check out the analysis of Crinetics Pharmaceuticals Correlation against competitors.
For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.

Latest Crinetics Pharmaceuticals' Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Crinetics Pharmaceuticals over the last few years. It is Crinetics Pharmaceuticals' Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Crinetics Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Crinetics Short Long Term Debt Total Regression Statistics

Arithmetic Mean8,745,693
Geometric Mean1,399,037
Coefficient Of Variation206.79
Mean Deviation11,806,802
Median2,024,000
Standard Deviation18,085,203
Sample Variance327.1T
Range54.1M
R-Value0.65
Mean Square Error204.4T
R-Squared0.42
Significance0.01
Slope2,620,135
Total Sum of Squares4579T

Crinetics Short Long Term Debt Total History

202454.3 M
202351.7 M
2022M
20213.1 M
2020M
20174.8 M

About Crinetics Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Crinetics Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Crinetics Pharmaceuticals investors use historical funamental indicators, such as Crinetics Pharmaceuticals's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Crinetics Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Crinetics Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Crinetics Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Crinetics Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Crinetics Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total51.7 M54.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Crinetics Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Crinetics Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Crinetics Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Crinetics Pharmaceuticals Stock:
Check out the analysis of Crinetics Pharmaceuticals Correlation against competitors.
For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Crinetics Stock analysis

When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Crinetics Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Crinetics Pharmaceuticals. If investors know Crinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Crinetics Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.72)
Revenue Per Share
0.032
Quarterly Revenue Growth
(0.76)
Return On Assets
(0.24)
Return On Equity
(0.41)
The market value of Crinetics Pharmaceuticals is measured differently than its book value, which is the value of Crinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Crinetics Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Crinetics Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Crinetics Pharmaceuticals' market value can be influenced by many factors that don't directly affect Crinetics Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Crinetics Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Crinetics Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Crinetics Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.